Maysam Yousefi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maysam Yousefi has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Anahita Behzadi
Social determinants of health research center, Institute for futures studies in health, Kerman University of Medical Sciences, Kerman, Iran
4 shared publications - Behnam Dalfardi
Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran
3 shared publications - Seyyid Mohammad Keyhan Sajadi
Health Foresight and Innovation Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
2 shared publications - Abbas Pardakhty
Pharmaceutics Research Center, Institute of Pharmaceutical Sciences, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication - Ahu Nakhaei Madih
Kerman University of Medical Sciences, Kerman, Iran
1 shared publication - Ali Hosseininasab
Department of Pediatrics, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication
Latest Publications
- Open Access
- 21 April 2025
- Published by Brieflands in Nephro-Urology Monthly
- Vol. 17 (2)
Examining the Influence of Vascular Access on Malnutrition, Inflammation and Atherosclerosis Syndrome in Hemodialysis: A Cross-sectional Study of Comparison Permcath and Fistula from Southeast Iran
Background: End-stage renal disease (ESRD) is characterized by malnutrition-inflammation-atherosclerosis (MIA) syndrome. Objectives: The present study aimed to compare the components of this syndrome between hemodialysis patients using a permcath and those using a fistula, focusing on how vascular access affects MIA syndrome. Methods: This cross-sectional study was conducted from June to August 2022 in two referral hospitals in Southeast Iran. Forty adult hemodialysis patients (≥ 18 years) with ESRD undergoing dialysis for at least six months were enrolled, divided equally into two groups based on vascular access type: Twenty individuals dialyzed using a permcath and twenty individuals using a fistula. The sample size was determined based on the exploratory nature of the research and the available patient population during the recruitment period. Malnutrition was assessed through serum albumin and Body Mass Index (BMI) measurements. Inflammatory markers, including erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), white blood cell (WBC) count, and serum ferritin levels, were evaluated to detect inflammation. Atherosclerosis was estimated by assessing mean carotid intima-media thickness (mean-CIMT), atherosclerotic plaques, and lipid profile parameters. Hypoalbuminemia was defined as serum albumin < 3.5 g/dL, and a mean CIMT > 1 mm was considered indicative of subclinical atherosclerosis. Potential confounders such as age, sex, primary kidney disease, and dialysis duration were considered. Statistical analyses included independent t-tests, Mann-Whitney U tests, and chi-square/Fisher’s exact tests, with a significance threshold of P < 0.05. Efforts were made to minimize bias by standardizing laboratory assessments, blinding radiologists to patient data, and ensuring comparable baseline characteristics between the groups. Results: Similar demographic and clinical characteristics were observed between the two groups. Among the malnutrition parameters, albumin levels differed significantly between the permcath and fistula groups (P = 0.03), while BMI showed no significant difference (P ≥ 0.05). Inflammation parameters were similar between the groups, with no significant differences observed (P ≥ 0.05). In terms of atherosclerosis, 30% of the permcath group had a high mean CIMT (> 1 mm) compared to none in the fistula group, demonstrating a significant difference (P = 0.008). However, unilateral and bilateral atherosclerotic plaques and serum triglyceride and cholesterol levels showed no statistically significant differences between the two groups (P ≥ 0.05). Conclusions: While both methods showed similar inflammatory profiles, hemodialysis using a fistula was associated with better nutritional status and a lower risk of atherosclerosis compared to permcath. These findings suggest that fistula-based hemodialysis may be preferable for reducing the risk of malnutrition and early atherosclerotic changes in ESRD patients.
- 21 April 2025
- Published by Brieflands in Nephro-Urology Monthly
- Vol. 17 (2)
Open AccessExamining the Influence of Vascular Access on Malnutrition, Inflammation and Atherosclerosis Syndrome in Hemodialysis: A Cross-sectional Study of Comparison Permcath and Fistula from Southeast Iran
Background: End-stage renal disease (ESRD) is characterized by malnutrition-inflammation-atherosclerosis (MIA) syndrome. Objectives: The present study aimed to compare the components of this syndrome between hemodialysis patients using a permcath and those using a fistula, focusing on how vascular access affects MIA syndrome. Methods: This cross-sectional study was conducted from June to August 2022 in two referral hospitals in Southeast Iran. Forty adult hemodialysis patients (≥ 18 years) with ESRD undergoing dialysis for at least six months were enrolled, divided equally into two groups based on vascular access type: Twenty individuals dialyzed using a permcath and twenty individuals using a fistula. The sample size was determined based on the exploratory nature of the research and the available patient population during the recruitment period. Malnutrition was assessed through serum albumin and Body Mass Index (BMI) measurements. Inflammatory markers, including erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), white blood cell (WBC) count, and serum ferritin levels, were evaluated to detect inflammation. Atherosclerosis was estimated by assessing mean carotid intima-media thickness (mean-CIMT), atherosclerotic plaques, and lipid profile parameters. Hypoalbuminemia was defined as serum albumin < 3.5 g/dL, and a mean CIMT > 1 mm was considered indicative of subclinical atherosclerosis. Potential confounders such as age, sex, primary kidney disease, and dialysis duration were considered. Statistical analyses included independent t-tests, Mann-Whitney U tests, and chi-square/Fisher’s exact tests, with a significance threshold of P < 0.05. Efforts were made to minimize bias by standardizing laboratory assessments, blinding radiologists to patient data, and ensuring comparable baseline characteristics between the groups. Results: Similar demographic and clinical characteristics were observed between the two groups. Among the malnutrition parameters, albumin levels differed significantly between the permcath and fistula groups (P = 0.03), while BMI showed no significant difference (P ≥ 0.05). Inflammation parameters were similar between the groups, with no significant differences observed (P ≥ 0.05). In terms of atherosclerosis, 30% of the permcath group had a high mean CIMT (> 1 mm) compared to none in the fistula group, demonstrating a significant difference (P = 0.008). However, unilateral and bilateral atherosclerotic plaques and serum triglyceride and cholesterol levels showed no statistically significant differences between the two groups (P ≥ 0.05). Conclusions: While both methods showed similar inflammatory profiles, hemodialysis using a fistula was associated with better nutritional status and a lower risk of atherosclerosis compared to permcath. These findings suggest that fistula-based hemodialysis may be preferable for reducing the risk of malnutrition and early atherosclerotic changes in ESRD patients.
- Open Access
- 15 March 2025
- Published by Brieflands in Journal of Archives in Military Medicine
- Vol. 13 (1)
Social Determinants of Health and Their Impact on Survival and Disease Progression in Patients with Brain Tumors at Shahid Bahonar Teaching Hospital in 2019
Background: Policymakers are increasingly prioritizing social justice in health, with the WHO's "Determinants of Health" framework advocating for equitable health distribution. Social factors such as income, education, and living conditions play a significant role in health outcomes, including cancer. Objectives: This study examines the relationship between social determinants of health and the survival rate of brain tumor patients at Shahid Bahonar Hospital in Kerman, Iran, in 2019. Methods: This cross-sectional study included 363 brain tumor patients, collecting data on demographics, treatment, and social factors. Statistical analysis was performed using SPSS, with survival rates analyzed through Kaplan-Meier and Cox regression models. Results: The mean age of the patients was 45.6 years, and 53.7% were male. Education, employment, family size, treatment type, and place of residence significantly influenced survival rates. Higher education was associated with longer survival, and employed patients had better survival rates than unemployed individuals. Additionally, smaller family size and combination therapy were linked to improved survival, while urban residents had longer survival compared to those in rural areas. Conclusions: The study highlights the importance of addressing socio-economic disparities to improve brain tumor patient outcomes. Ensuring equitable access to diagnosis and treatment for all individuals is crucial for reducing health disparities and enhancing survival rates.
- 15 March 2025
- Published by Brieflands in Journal of Archives in Military Medicine
- Vol. 13 (1)
Open AccessSocial Determinants of Health and Their Impact on Survival and Disease Progression in Patients with Brain Tumors at Shahid Bahonar Teaching Hospital in 2019
Background: Policymakers are increasingly prioritizing social justice in health, with the WHO's "Determinants of Health" framework advocating for equitable health distribution. Social factors such as income, education, and living conditions play a significant role in health outcomes, including cancer. Objectives: This study examines the relationship between social determinants of health and the survival rate of brain tumor patients at Shahid Bahonar Hospital in Kerman, Iran, in 2019. Methods: This cross-sectional study included 363 brain tumor patients, collecting data on demographics, treatment, and social factors. Statistical analysis was performed using SPSS, with survival rates analyzed through Kaplan-Meier and Cox regression models. Results: The mean age of the patients was 45.6 years, and 53.7% were male. Education, employment, family size, treatment type, and place of residence significantly influenced survival rates. Higher education was associated with longer survival, and employed patients had better survival rates than unemployed individuals. Additionally, smaller family size and combination therapy were linked to improved survival, while urban residents had longer survival compared to those in rural areas. Conclusions: The study highlights the importance of addressing socio-economic disparities to improve brain tumor patient outcomes. Ensuring equitable access to diagnosis and treatment for all individuals is crucial for reducing health disparities and enhancing survival rates.
- Open Access
- 9 January 2024
- Published by Brieflands in Archives of Clinical Infectious Diseases
- Vol. 19 (1)
Short-term Safety of Covaxin, Sinopharm, Sputnik V, and AstraZeneca COVID-19 Vaccines Among Iranian Healthcare Workers: A Cross-Sectional Study
Background: Several coronavirus disease 2019 (COVID-19) vaccines, utilizing different platforms, have successfully obtained emergency clinical use authorization to prevent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections. Most published data from COVID-19 vaccine trials have frequently observed mild-to-moderate side effects, with varying severity depending on various vaccine types. Objectives: This study aimed to estimate the prevalence of side effects associated with four types of COVID-19 vaccines among vaccinated healthcare workers following the first and second vaccine doses and to identify possible risk factors for COVID-19 vaccine side effects. Methods: This cross-sectional study was conducted from April 2021 to March 2022 by administering a questionnaire and conducting direct interviews with healthcare workers in Kerman, southeastern Iran, who had received 2 or more doses of COVID-19 vaccines. Results: Out of 861 individuals enrolled in the study, 38.7% received Sputnik, 32.4% AstraZeneca, 19.6% Covaxin, and 9.3% Sinopharm vaccines. Overall, the most common side effects after the first and second doses included general symptoms, fever and chills, injection site reactions, neurological symptoms, and gastrointestinal symptoms. Furthermore, the frequency of symptoms significantly reduced after the second dose. Conclusions: General symptoms and injection site reactions were significantly more common after receiving the first dose of vaccines compared to the second dose. No severe vaccine side effects were observed in this study. However, further research is required to evaluate the long-term symptoms and safety profiles of COVID-19 vaccines.
- 9 January 2024
- Published by Brieflands in Archives of Clinical Infectious Diseases
- Vol. 19 (1)
Open AccessShort-term Safety of Covaxin, Sinopharm, Sputnik V, and AstraZeneca COVID-19 Vaccines Among Iranian Healthcare Workers: A Cross-Sectional Study
Background: Several coronavirus disease 2019 (COVID-19) vaccines, utilizing different platforms, have successfully obtained emergency clinical use authorization to prevent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections. Most published data from COVID-19 vaccine trials have frequently observed mild-to-moderate side effects, with varying severity depending on various vaccine types. Objectives: This study aimed to estimate the prevalence of side effects associated with four types of COVID-19 vaccines among vaccinated healthcare workers following the first and second vaccine doses and to identify possible risk factors for COVID-19 vaccine side effects. Methods: This cross-sectional study was conducted from April 2021 to March 2022 by administering a questionnaire and conducting direct interviews with healthcare workers in Kerman, southeastern Iran, who had received 2 or more doses of COVID-19 vaccines. Results: Out of 861 individuals enrolled in the study, 38.7% received Sputnik, 32.4% AstraZeneca, 19.6% Covaxin, and 9.3% Sinopharm vaccines. Overall, the most common side effects after the first and second doses included general symptoms, fever and chills, injection site reactions, neurological symptoms, and gastrointestinal symptoms. Furthermore, the frequency of symptoms significantly reduced after the second dose. Conclusions: General symptoms and injection site reactions were significantly more common after receiving the first dose of vaccines compared to the second dose. No severe vaccine side effects were observed in this study. However, further research is required to evaluate the long-term symptoms and safety profiles of COVID-19 vaccines.
- Open Access
- 28 December 2023
- Published by Brieflands in Archives of Clinical Infectious Diseases
- Vol. 18 (6)
Side Effects and Short-term Safety of COVID-19 Vaccines for Pregnant Women: A Case Study of Southeast Iran
Background: This study aimed to investigate the possible side effects and short-term safety of coronavirus disease 2019 (COVID-19) vaccines in pregnant women. Methods: This cross-sectional study was conducted on a sample of 500 pregnant women who had received various types of COVID-19 vaccines between June and August 2022. The participants were selected using convenience sampling until the desired sample size was achieved. Data analysis was performed using SPSS software (version 20). Results: The mean age of the participants was 30 years, and 34.2% of them had a history of COVID-19 infection. Furthermore, 40 of the participants had underlying hypothyroidism, and 13 cases were smokers. The most commonly reported side effects were abdominal pain, fatigue, headache, and fever; nevertheless, the lowest frequency was associated with localized swelling (0%) and ageusia, localized pruritus, and urticaria (0.4%). Conclusions: There was no increase in miscarriage or serious side effects observed as a result of COVID-19 vaccination in pregnant women.
- 28 December 2023
- Published by Brieflands in Archives of Clinical Infectious Diseases
- Vol. 18 (6)
Open AccessSide Effects and Short-term Safety of COVID-19 Vaccines for Pregnant Women: A Case Study of Southeast Iran
Background: This study aimed to investigate the possible side effects and short-term safety of coronavirus disease 2019 (COVID-19) vaccines in pregnant women. Methods: This cross-sectional study was conducted on a sample of 500 pregnant women who had received various types of COVID-19 vaccines between June and August 2022. The participants were selected using convenience sampling until the desired sample size was achieved. Data analysis was performed using SPSS software (version 20). Results: The mean age of the participants was 30 years, and 34.2% of them had a history of COVID-19 infection. Furthermore, 40 of the participants had underlying hypothyroidism, and 13 cases were smokers. The most commonly reported side effects were abdominal pain, fatigue, headache, and fever; nevertheless, the lowest frequency was associated with localized swelling (0%) and ageusia, localized pruritus, and urticaria (0.4%). Conclusions: There was no increase in miscarriage or serious side effects observed as a result of COVID-19 vaccination in pregnant women.
- Open Access
- 2 October 2023
- Published by Brieflands in Journal of Archives in Military Medicine
- Vol. 11 (3)
Comparison of Blood Culture and Serum Levels of Anti-Brucella Antibodies in Spontaneous Abortions with Successful Pregnancies: A Case Study of Southeastern Iran
Background: This study aimed to compare blood culture and serum levels of anti-Brucella antibodies between pregnancies leading to abortion and successful pregnancies. Methods: In this case-control study, 60 women with spontaneous abortions were considered the case group, and 60 women with normal pregnancy outcomes were selected as the control group. Both groups were matched. The serology of IgM and IgG antibodies and blood culture was also compared using the enzyme-linked immuno-sorbent assay (ELISA) method. IgM and IgG levels above and equal to 12 were considered positive titers, and data were analyzed using SPSS software version 20. Results: The mean age of mothers (P ≤ 0.364), the frequency of positive blood cultures for Brucella (P ≤ 0.157), seropositivity of anti-Brucella IgG (P ≤ 0.300), and seropositivity of anti-Brucella IgM (P ≤ 0.057) showed no significant differences between case and control groups; however, mean serum levels of IgM were significantly higher in women with abortion than in the control group (P ≤ 0.042). Conclusions: This study shows that Brucella seropositivity and positive blood culture are no more common in women with spontaneous abortions than in women with normal pregnancy outcomes. However, screening pregnant women for diseases in endemic areas, starting antibiotic treatment, and developing educational strategies for women of childbearing age will help prevent the disease and its adverse complications in pregnancy.
- 2 October 2023
- Published by Brieflands in Journal of Archives in Military Medicine
- Vol. 11 (3)
Open AccessComparison of Blood Culture and Serum Levels of Anti-Brucella Antibodies in Spontaneous Abortions with Successful Pregnancies: A Case Study of Southeastern Iran
Background: This study aimed to compare blood culture and serum levels of anti-Brucella antibodies between pregnancies leading to abortion and successful pregnancies. Methods: In this case-control study, 60 women with spontaneous abortions were considered the case group, and 60 women with normal pregnancy outcomes were selected as the control group. Both groups were matched. The serology of IgM and IgG antibodies and blood culture was also compared using the enzyme-linked immuno-sorbent assay (ELISA) method. IgM and IgG levels above and equal to 12 were considered positive titers, and data were analyzed using SPSS software version 20. Results: The mean age of mothers (P ≤ 0.364), the frequency of positive blood cultures for Brucella (P ≤ 0.157), seropositivity of anti-Brucella IgG (P ≤ 0.300), and seropositivity of anti-Brucella IgM (P ≤ 0.057) showed no significant differences between case and control groups; however, mean serum levels of IgM were significantly higher in women with abortion than in the control group (P ≤ 0.042). Conclusions: This study shows that Brucella seropositivity and positive blood culture are no more common in women with spontaneous abortions than in women with normal pregnancy outcomes. However, screening pregnant women for diseases in endemic areas, starting antibiotic treatment, and developing educational strategies for women of childbearing age will help prevent the disease and its adverse complications in pregnancy.
- Open Access
- 30 May 2022
- Published by Brieflands in Archives of Clinical Infectious Diseases
- Vol. 16 (6)
Short-time Safety of the Sinopharm COVID-19 Vaccine in Patients with Hemophilia
Background: The COVID-19 pandemic, caused by SARS-Cov-2, has affected the care of patients with hemophilia, indicating the necessity of their vaccination. Nevertheless, there are concerns about using anti-SARS-Cov-2 virus vaccines for hemophilic patients, particularly concerning bleeding adverse events. Methods: Following a cross-sectional design, all adult hemophilic patients who received two doses of Sinopharm anti-SARS-Cov-2 virus vaccine in Afzalipour Hospital, Kerman, Iran, during May and June 2021 were recruited. The participants were followed for two weeks after receiving each dose of vaccine. Results: Fifty-one patients with a mean age of 37.07 ± 11.45 years were included, of whom 27 (61.4 %) patients experienced at least one adverse reaction. Pain was the most frequent local adverse event (occurred in 20 (39.2%) and 15 (29.4%) cases after 1st and 2nd doses, respectively). Menometrorrhagia and epistaxis were reported by two and one patients, respectively. Conclusions: Overall Sinopharm anti-SARS-Cov-2 virus vaccine seems to be safe for patients with hemophilia in the short term.
- 30 May 2022
- Published by Brieflands in Archives of Clinical Infectious Diseases
- Vol. 16 (6)
Open AccessShort-time Safety of the Sinopharm COVID-19 Vaccine in Patients with Hemophilia
Background: The COVID-19 pandemic, caused by SARS-Cov-2, has affected the care of patients with hemophilia, indicating the necessity of their vaccination. Nevertheless, there are concerns about using anti-SARS-Cov-2 virus vaccines for hemophilic patients, particularly concerning bleeding adverse events. Methods: Following a cross-sectional design, all adult hemophilic patients who received two doses of Sinopharm anti-SARS-Cov-2 virus vaccine in Afzalipour Hospital, Kerman, Iran, during May and June 2021 were recruited. The participants were followed for two weeks after receiving each dose of vaccine. Results: Fifty-one patients with a mean age of 37.07 ± 11.45 years were included, of whom 27 (61.4 %) patients experienced at least one adverse reaction. Pain was the most frequent local adverse event (occurred in 20 (39.2%) and 15 (29.4%) cases after 1st and 2nd doses, respectively). Menometrorrhagia and epistaxis were reported by two and one patients, respectively. Conclusions: Overall Sinopharm anti-SARS-Cov-2 virus vaccine seems to be safe for patients with hemophilia in the short term.